ArticleEndocrine, metabolic & immune disorders drug targets2024
Focus on Non-osteoporotic Post-menopausal Women with Asymptomatic Primary Hyperparathyroidism: A Monocentric Series.
Elena Castellano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.